The approval process for new drug delivery systems in South Korea involves submitting detailed data on safety, efficacy, and functionality to the Ministry of Food and Drug Safety (MFDS). Preclinical and clinical trial data must demonstrate the system’s performance, stability, and patient benefits. Regulatory review ensures compliance with quality standards before market approval.